Revenue · 2016–2025

Karyopharm Therapeutics revenue

$146M+0.6% · FY2025

Karyopharm Therapeutics (KPTI) reported $146M in revenue for fiscal 2025, +0.6% year on year.

$154,0002016$1.6M2017$30.3M2018$40.9M2019$108M2020$210M2021$157M2022$146M2023$145M2024$146M2025
Karyopharm Therapeutics — Revenue, 2016–2025
Fiscal yearRevenueChangeFiling
FY20252025-12-31$146M+0.6%Open →
FY20242024-12-31$145M−0.5%Open →
FY20232023-12-31$146M−7.0%Open →
FY20222022-12-31$157M−25.1%Open →
FY20212021-12-31$210M+94.1%Open →
FY20202020-12-31$108M+164.3%Open →
FY20192019-12-31$40.9M+34.8%Open →
FY20182018-12-31$30.3M+1,790.1%Open →
FY20172017-12-31$1.6M+942.2%Open →
FY20162016-12-31$154,000—Open →

Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +114.2%

Revenue at companies of similar size

Full ranking by revenue →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Karyopharm Therapeutics revenue |url=https://companiesranked.com/en/company/karyopharm-therapeutics/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Karyopharm Therapeutics revenue. CompaniesRanked. https://companiesranked.com/en/company/karyopharm-therapeutics/revenue

BibTeX

@misc{companiesranked-en-company-karyopharm-therapeutics-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Karyopharm Therapeutics revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/karyopharm-therapeutics/revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001193125-26-049397 · February 13, 2026

{{cite web |title=Karyopharm Therapeutics revenue — 10-K (0001193125-26-049397) |url=https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-13}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Karyopharm Therapeutics overview